ABVX Earnings Date: Dec 21, 2026 (Estimated) — Abivax SA American Depositary Shares
XNAS
Updated
When is ABVX's next earnings date?
Abivax SA American Depositary Shares (ABVX) is expected to report earnings on Monday, December 21, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.92 on revenue of $922,549.
How did ABVX do in its last earnings report?
In its most recent report on Sep 21, 2026 (H1 2026), Abivax SA American Depositary Shares posted EPS of -$2.43 versus the -$1.03 estimate, a miss of 125.0%. Revenue was $3.0M against a $799,166 estimate. The stock's 1-day post-earnings move was -5.0%.
How much does ABVX stock move after earnings?
ABVX beat EPS estimates in 0 of its last 4 reported quarters. Over the last 5 reports the stock moved an average of 2.6% (up or down) in the day after earnings.
About Abivax SA American Depositary Shares
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 | H1 2026 | -1.03 | -2.43 | -125.00% | $3.0M | ❌ Miss | -4.99% | -6.38% | -10.50% |
| 2026-03-23 | FY 2025 | -4.91 | -5.45 | -11.00% | $5.2M | ❌ Miss | -4.55% | -12.06% | +0.49% |
| 2025-03-24 | FY 2024 | — | -2.99 | — | $13.3M | — | -0.14% | -12.87% | -11.92% |
| 2024-09-09 | H1 2024 | — | -1.41 | — | $7.4M | — | -2.83% | -5.10% | -22.51% |
| 2024-04-02 | FY 2023 | -2.38 | -3.71 | -55.92% | $5.0M | ❌ Miss | +0.50% | +8.02% | +7.37% |
| 2022-12-30 | -1.93 | -1.95 | — | $2.4M | ❌ Miss | — | — | — | |
| 2022-09-15 | — | -1.84 | — | $2.3M | — | — | — | — | |
| 2022-03-16 | — | -1.68 | — | — | — | — | — | — |
Showing last 8 quarters.